Skip to main content

House Democrats launch drug-pricing probe into a dozen major health-care companies

By CNBC  
   January 14, 2019

The House Oversight Committee is investigating the actions of a dozen pharmaceutical companies. Chairman Elijah Cummings, D-Md., sent letters to AbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals.

Full story


Get the latest on healthcare leadership in your inbox.